Estimated Health Outcomes and Costs of COVID-19 Prophylaxis With Monoclonal Antibodies Among Unvaccinated Household Contacts in the US

IMPORTANCE: The COVID-19 pandemic has led to more than 900 000 deaths in the US and continues to disrupt lives even as effective vaccines are available. OBJECTIVE: To estimate the health outcomes and net cost of implementing postexposure prophylaxis (PEP) with monoclonal antibodies (mAbs) against ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Flaxman, Abraham D., Issema, Rodal, Barnabas, Ruanne V., Ross, Jennifer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034404/
https://www.ncbi.nlm.nih.gov/pubmed/35452104
http://dx.doi.org/10.1001/jamanetworkopen.2022.8632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034404/
https://www.ncbi.nlm.nih.gov/pubmed/35452104
http://dx.doi.org/10.1001/jamanetworkopen.2022.8632

Ejemplares similares